What is the primary focus of the rational design and characterization of trispecific antibodies targeting the HIV-1 receptor and envelope glycoprotein?
a) Treatment of influenza
b) Targeting cancer cells
c) Combatting bacterial infections
d) Addressing HIV-1 infection
